DNA
$0.84
Revenue | $34.76Mn |
Net Profits | $-211.69Mn |
Net Profit Margins | -609.1% |
Ginkgo Bioworks Holdings Inc’s revenue fell -64.64% since last year same period to $34.76Mn in the Q4 2023. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated -37.3% fall in its revenue since last 3-months.
Ginkgo Bioworks Holdings Inc’s net profit fell -21.56% since last year same period to $-211.69Mn in the Q4 2023. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated 30.11% jump in its net profits since last 3-months.
Ginkgo Bioworks Holdings Inc’s net profit margin fell -243.75% since last year same period to -609.1% in the Q4 2023. On a quarterly growth basis, Ginkgo Bioworks Holdings Inc has generated -11.47% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.08 |
EPS Estimate Current Year | -0.08 |
Ginkgo Bioworks Holdings Inc’s earning per share (EPS) estimates for the current quarter stand at -0.08 - a 18% jump from last quarter’s estimates.
Ginkgo Bioworks Holdings Inc’s earning per share (EPS) estimates for the current year stand at -0.08.
Earning Per Share (EPS) | 0 |
Ginkgo Bioworks Holdings Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2024. This indicates that the Ginkgo Bioworks Holdings Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-13 | -0.08 | 0 | 100% |